Patents and Published Applications Developed for PharmaDirections' Clients

  1. R. Soltero, N. Ekwirube, F. Opawale, A. Hickey, B. Rehaender, L. Bovet, "Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith" United States Patent 6,770,625

  2. R. Soltero, N. Ekwirube, B. Rehaender, L. Bovet, A. Hickey, "Pharmaceutical Compositions of Insulin Drug-Oligomer Conjugates and Methods of Treating Diseases Therewith" United States Patent 6,867,183

  3. R. Soltero, B. Radhakrishnan, N. Ekwirube, "Methods of Synthesizing Insulin Polypeptide-Oligomer Conjugates, and Proinsulin Polypeptide-Oligomer Conjugates and Methods of Synthesizing Same" United States Patent 6,913,903

  4. R. Soltero, N. Ekwirube, F. Opawale, B. Rehaender, A. Hickey, "Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith” United States Patent 7,030,082

  5. R. Soltero, B. Radhakrishnan, N. Ekwirube, “Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same" United States Patent 7,166,571

  6. R. Soltero, B. Radhakrishnan, N. Ekwirube, B. Rehaender, A. Hickey, L. Bovet, "Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith" United States Patent 7,196,059

  7. B. Radhakrishnan, R. Soltero, N. Ekwirube, M. Puskas, D. Sangal, "Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same" United States Patent 7,312,192

  8. B. Radhakrishnan, R. Soltero, N. Ekwirube, "Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same" United States Patent 7,368,260

  9. R. Soltero, N. Ekwuribe, F. Opawale, B. Rehlander, A. Hickey, L. Bovet, "Pharmaceutical compositions of drug-oligomer conjugates and methods of treating diseases therewith" United States Patent Application 20030069170

  10. J. G. Still, R. Soltero, et al., "Methods of Reducing Hypoglycemic Episodes in the Treatment of Diabetes Mellitus" United States Patent Application 20040038867

  11. F. Opawale, R. Soltero, "Micro-particle fatty acid salt solid dosage formulations for therapeutic agents" United States Patent Application 20050095216

  12. R. Soltero, "Method for administering medicaments to subjects with swallowing difficulties and disorders" United States Patent Application 20070196495

  13. A. McKinney, G. Tollefson, S. Yau, R. Vladyka, R. Soltero, "Sustained Release Formulations of Zonisamide" United States Patent Application 20070148237

  14. G. Tollefson, A. McKinney. M. Higgin, J. McCall, "Compositions for affecting weight loss" United States Patent Application 20070117827

  15. A. McKinney, G. Tollefson, R. Soltero, E. Dunzo, "Sustained Release Formulations of Naltrexone" United States Patent Application 20070281021

  16. A. McKinney, G. Tollefson, E. Weber, R. Soltero, "Methods for Administering Weight Loss Medications" United States Patent Application 20080110792

  17. A. McKinney, G. Tollefson, E. Weber, R. Soltero, "Layered Pharmaceutical Formulations" United States Patent Application 20080113026

  18. R. Soltero, "System and Method for Developing and Managing a Manufacturing Process" United States Patent Application 20080097804

  19. R. Soltero, B. Rehlander, "A Method for Stabilizing Acidic and Alkaline Labile Pharmaceutical Products" PTO Application Number 61059290

Other Issued Patents and Published Patent Applications with PDI Staff as Inventors

  1. US 4,546,193: Antiarrhythmic cyclooct[b]indoles

  2. US 4,638,008: Antiarrhythmic agents

  3. US 4,665,227: N-substituted-4(3)-nitrobenzene sulphonamides

  4. US 4,698,445: 4-amino benzenesulfonamides

  5. US 4,721,809: Alkylsulfonamido or perfluoroalkylsulfonamido benzenesulfonamides

  6. US 4,794,196: N-aminoalkylperfluoroalkanoylaminobenzene-sulfonamide anti-arrhythmic agents

  7. US 5,002,949: 5-substituted-6-aminopyrimidine derivatives

  8. US 5,144,072: Anti-arrhythmic agents

  9. US 6,037,358: Decongestant/antihistaminic compositions

  10. US 6,287,597: Decongestant/antihistaminic compositions

  11. US 6,306,904: Antihistaminic/antitussive compositions

  12. US 6,586,469: Antihistaminic/antitussive compositions

  13. US 6,630,498: Eprosartan arginyl charge-neutralization-complex and a process for its preparation and formulation

  14. US D383,533: Pharmaceutical tablet

  15. US D383,534: Pharmaceutical tablet

Click here for list in PDF format